Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Antiseptic Additional Identity Statement, Indications Requested By Gojo

This article was originally published in The Tan Sheet

Executive Summary

FDA should expand "statements of identity" under the OTC topical antimicrobial products tentative final monograph to allow products to be labeled as "hand sanitizers," according to Gojo Industries

You may also be interested in...

Triclocarban 1.5% Category I Antimicrobial Status Sought By P&G

FDA should include triclocarban at levels of up to 1.5% as a Category I ingredient in its OTC topical antimicrobial products final monograph, Procter & Gamble states in Aug. 19 comments to the agency

Antimicrobial monograph

FDA is reopening administrative record for OTC topical antimicrobial drug products monograph until Aug. 27 to accept comments and data on OTC healthcare antiseptic drugs, agency says in 1May 29 Federal Register notice. Record for TFM closed in August 1995, but FDA has since received several petitions and comments containing new data on proposed non-monograph ingredients and testing criteria for antiseptic drugs. FDA has determined "good cause exists" to review new information, as it is relevant to final ingredient classification and testing criteria. Comments previously submitted need not be resubmitted, additional comments should only address data provided after 1995. Triclosan, salicylic acid among ingredients requested by industry for Category I status; CTFA and SDA have submitted data on test protocols, antimicrobial performance, filing four petitions in 2001 alone (2"The Tan Sheet" Dec. 10, 2001, p. 4)...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts